Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1

By sjmartinez • October 4, 2022

Youn JY, Wang J, Li Q, Huang K, Cai H. Robust therapeutic effects on COVID-19 of novel small molecules: Alleviation of SARS-CoV-2 S protein induction of ACE2/TMPRSS2, NOX2/ROS, and MCP-1. Front Cardiovasc Med. 2022 Sep 15;9:957340. doi: 10.3389/fcvm.2022.957340. PMID: 36187008; PMCID: PMC9520320.

Tags: acute respiratory distress syndrome (ARDS), Cardiology/Epi, covid-19, endothelial dysfunction, NADPH oxidase isoform 2 (NOX2), Publications, SARS-CoV-2

Pharmacological treatments and clinical events in newly diagnosed heart failure patients stratified by ejection fraction in Japan

Sato N, Okami S, Yoshikawa-Ryan K, Yamashita S, Kobayashi R, Arita Y, Kim SW, Knapp R, Holl K, Fonarow GC. Pharmacological treatments and clinical events[...]

Orchestration of Endothelial and Osteogenic Marker Expression During Osteogenesis

Chen S, Zhao Y, Chen N, Wu X, Zhang L, Jing Z, Qi L, Cai X, Boström KI, Yao Y. Orchestration of Endothelial and Osteogenic[...]

Sex Differences in Cancer and Cardiotoxicity: Mechanisms, Outcomes, and Clinical Implications Across Solid and Hematological Malignancies

Keramida K, Aznar MC, Bergler-Klein J, Boriani G, Cardinale D, Dent S, Drakaki A, Fuster JJ, Mamas MA, Okwuosa T, Scarfo L, Van Der Meer[...]